Prevalence of HIV-related stigma manifestations and their contributing factors among people living with HIV in Sweden – a nationwide study

BMC Public Health, Год журнала: 2024, Номер 24(1)

Опубликована: Май 20, 2024

Abstract Background With access to antiretroviral therapy (ART) HIV infection is a chronic manageable condition and non-sexually transmissible. Yet, many people living with still testify about experiencing HIV-related stigma discrimination. It well-documented that discrimination continue be critical barriers prevention, treatment, care quality of life. From an individual stigma-reduction intervention perspective, it essential identify interpersonal factors associated manifestations. To address this issue expand the literature, aim study was assess prevalence manifestations their among diverse sample in Sweden. Method Data from 1 096 participants were derived nationally representative, anonymous cross-sectional survey ”Living Sweden”. assessed using validated Swedish 12-item Stigma Scale encompassing four manifestations: personalised stigma, concerns public attitudes towards HIV, sharing status, internalized stigma. Variables potentially divided into categories: demographic characteristics, clinical factors, distress ART adherence, available emotional support. Four multivariable hierarchical linear regression analyses employed explore associations between multiple contributors Results The most dominating feature anticipation manifested high scores on status reported by 78% 54% participants. High around one third respectively. Between 23 31% variance explained mainly same pattern including female gender, shorter time since diagnosis, feelings hopelessness, non-sharing lack Conclusion Female support constituted potential vulnerability Our findings highlight vital necessity increase resilience its different forms. Exploring may give indication what circumstances risk burden amenable targeted interventions. As stigma-reductions interventions cannot performed isolated society, key challenge intensify anti-stigma also societal level.

Язык: Английский

Questioning the “Ease” in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV)

PLoS ONE, Год журнала: 2024, Номер 19(3), С. e0295223 - e0295223

Опубликована: Март 7, 2024

Introduction Clinical research has focused on risk factors and treatment for severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), particularly in people with a comorbidity including the human immunodeficiency virus (HIV), but little attention been paid to care pathway. This article aims show how living HIV may have biopsychosocial burden or boost pathways Covid-19. Method People (PLHIV) from 9 clinical centers were invited participate this qualitative study. The sampling was purposive maximum variation their sociodemographic profiles. Semi-structured interviews conducted until data saturation, then coded thematic analysis, using an inductive general approach. Results We interviewed 34 PLHIV of which 20 had SARS-COV-2 once. They 24 males, 26 born France; median age: 55. Twenty CD4 number above 500, all antiretroviral therapy (ART). appeared as when Covid-19 symptoms reminded seroconversion, fear contamination, triggered questions about ART effectiveness. not considered relevant diagnosing Covid-19, caused disclosure participants sought testing, its hospitals disrupted by pandemic. ART-pill fatigue avoidance treatment. As boost, led observe symptoms, get advice healthcare professionals, screening access through them. Some could accept result diagnosis out resilience. consider another drug prescribed specialist help them recover Conclusion Living function and/or according patients’ relationship history, comorbidities representation ART. needs further study gain more comprehensive assessment pandemic’s consequences lives coping strategies.

Язык: Английский

Prevalence of HIV-related stigma among people with HIV in Switzerland: addressing the elephant in the room

AIDS, Год журнала: 2024, Номер 38(13), С. 1874 - 1884

Опубликована: Июль 24, 2024

Objectives: We aimed to determine the prevalence of HIV-related stigma among people with HIV (PWH) in Switzerland Design: A cross-sectional multicenter study nested within Swiss Cohort Study (SHCS). Methods: included adult PWH enrolled SHCS, attending follow-up between March 1, 2020, and January 31, 2021. Inability speak English, French, German, or Italian was only exclusion criterion. Participants were invited complete a validated 12-item HIV-stigma questionnaire comprising four subscales (negative self-image, personalized stigma, disclosure concerns, concerns regarding public attitudes), plus two healthcare-related items. Questionnaire responses graded using four-point Likert-type scale, higher scores indicating stigma. “Non-applicable,” inferring HIV-status non-disclosure, possible for stigma; from participants answering “non-applicable” at least one item analyzed separately. Factors associated identified through multivariable linear models. Results: Of 9643 SHCS visit, 5563 participated study: 26% female, 13% Black, 37% heterosexual; median age 53 years (interquartile range 44–59); 2067 (37%) gave response. Disclosure had highest reported by 4656/5563 (84%). across all demographic groups. However, being heterosexual independently scores. Higher education longer duration lower Healthcare-related participants. Conclusion: prevalent The association female Black suggests that accentuates preexisting sex race inequalities.

Язык: Английский